Century Therapeutics, Inc. Sustainability Profile
Century Therapeutics, Inc., a pioneering biotechnology firm headquartered in the United States, focuses on developing innovative cell therapies for cancer treatment. Founded in 2018, the company has rapidly established itself in the biopharmaceutical industry, particularly in the realm of induced pluripotent stem cell (iPSC) technology. With a commitment to advancing personalised medicine, Century Therapeutics is dedicated to creating off-the-shelf cell therapies that harness the power of the immune system. Their unique approach aims to improve patient outcomes by providing more effective and accessible treatment options. Notable achievements include strategic partnerships and advancements in their clinical pipeline, positioning Century Therapeutics as a leader in the evolving landscape of cancer therapeutics. As they continue to push the boundaries of science, Century Therapeutics remains focused on transforming the future of oncology care.
DitchCarbon Score
How does Century Therapeutics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Century Therapeutics, Inc.'s score of 23 is lower than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Century Therapeutics, Inc.'s reported carbon emissions
Century Therapeutics, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Century Therapeutics may still be in the early stages of developing its climate commitments or reporting frameworks. As the biotechnology industry increasingly prioritises sustainability, it is essential for companies like Century Therapeutics to establish clear emissions reduction strategies and targets. This would not only align with global climate initiatives but also enhance their reputation and operational resilience in a competitive market.
How Carbon Intensive is Century Therapeutics, Inc.'s Industry?
How Carbon Intensive is Century Therapeutics, Inc.'s Location?
Century Therapeutics, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Century Therapeutics, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
